Literature DB >> 3554627

Effect of charcoal and sorbitol-charcoal suspension on the elimination of intravenous phenobarbital.

M J Berg, J Q Rose, D E Wurster, S Rahman, R W Fincham, D D Schottelius.   

Abstract

The effects of two different oral charcoal suspensions on the elimination of a 200 mg/70 kg, 1 h intravenous (i.v.) infusion of phenobarbital and the tolerances of the two regimens were determined in a randomized crossover study in six healthy male volunteers. Phenobarbital was given i.v. alone or together with 105 g of oral activated charcoal suspension or with 105 g of a commercially available sorbitol-charcoal suspension over a 36-h period. A 13-34% decrease in the area under the serum concentration time curve (AUC) for 0-60 h occurred with the administration of the activated charcoal, and a 19-52% decrease occurred with the commercial sorbitol-charcoal regimen. The mean apparent systemic clearance of total phenobarbital increased from 0.089 +/- 0.019 ml/min/kg to 0.141 +/- 0.029 and 0.146 +/- 0.036 ml/min/kg with the charcoal and sorbitol-charcoal treatments, respectively. No significant change in the fraction of phenobarbital bound to protein was detected. The charcoal regimen caused constipation in one subject. All subjects taking the sorbitol-charcoal preparation experienced diarrhea; there were no changes in electrolytes with either charcoal suspension. All subjects preferred the sorbitol-charcoal preparation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3554627     DOI: 10.1097/00007691-198703000-00008

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  6 in total

1.  Phenobarbital adsorption from simulated intestinal fluid, U.S.P., and simulated gastric fluid, U.S.P., by two activated charcoals.

Authors:  D E Wurster; G M Burke; M J Berg; P Veng-Pedersen; D D Schottelius
Journal:  Pharm Res       Date:  1988-03       Impact factor: 4.200

2.  Phenobarbital removal characteristics of three brands of activated charcoals: a system analysis approach.

Authors:  N B Modi; P Veng-Pedersen; D E Wurster; M J Berg; D D Schottelius
Journal:  Pharm Res       Date:  1994-02       Impact factor: 4.200

3.  Kinetics of drug action in disease states. XXXIX. Effect of orally administered activated charcoal on the hypnotic activity of phenobarbital and the neurotoxicity of theophylline administered intravenously to rats with renal failure.

Authors:  A Hoffman; G Levy
Journal:  Pharm Res       Date:  1990-03       Impact factor: 4.200

Review 4.  Oral activated charcoal in the treatment of intoxications. Role of single and repeated doses.

Authors:  P J Neuvonen; K T Olkkola
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Jan-Dec

Review 5.  Activated charcoal for acute overdose: a reappraisal.

Authors:  David N Juurlink
Journal:  Br J Clin Pharmacol       Date:  2015-11-09       Impact factor: 4.335

6.  Antiepileptic Overdose.

Authors:  Shakuntala Murty
Journal:  Indian J Crit Care Med       Date:  2019-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.